Ekso Bionics Holdings, Inc. Common Stock (CHRN) | AI Infrastructure Stock

Ekso Bionics Holdings, Inc. Common Stock
CHRN
$21.50 (-4.18%)
Last update 08:00 PM UTC · Jul 24 · NASDAQ
#84 AI Infrastructure
Ekso Bionics Holdings, Inc. Common Stock
CHRN
#84 in AI Infrastructure
AI Infrastructure Stock · NASDAQ · San Rafael, US
$21.50 (-4.18%)
Last update 08:00 PM UTC · Jul 24, 2026

Market

Market Overview

Market Cap
$76,612,670
Shares Outstanding
3,563,380
50-Day Moving Average
$20.16
200-Day Moving Average
$17.4
Average Volume (20 Days)
366,443
Beta (5Y)
0.99

Price History

Date OPEN HIGH LOW CLOSE VWAP VOLUME %CHG $CHG

About

Ekso Bionics Holdings, Inc. Common Stock Company Overview

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Stock Exchange NASDAQ
IPO Date 2026-05-05
Number of Employees 55
Headquarters San Rafael, US

Key Executives

News & Filings

Press Releases

No press releases found.

SEC Filings

Form Type Filed Accepted Source

Earnings Call Summaries

CHRN Frequently Asked Questions

The next earnings report date for Ekso Bionics Holdings, Inc. Common Stock (CHRN) is scheduled for July 27, 2026. Stay up to date with ’s financial results and key announcements by visiting our Earnings Tracker or by subscribing to earnings alerts. Here we also provide CHRN earnings call summaries and transcripts.

The current stock price of Ekso Bionics Holdings, Inc. Common Stock (CHRN) is $21.5 as of 08:00 PM UTC · Jul 24, 2026 . For live stock updates and company rankings, view our Bitcoin mining stocks by market cap table.

The latest news for Ekso Bionics Holdings, Inc. Common Stock (CHRN) includes ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure Strategy published on June 4, 2026 . For more details and ongoing updates, visit the CHRN news section.